Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
CESC | rs17165351 | chr5:126132255 | T/C | 0 | 294 | 21.23 | 20.63 | 1.73 | KM Plot |
CESC | rs17303178 | chr12:12485351 | G/A | 0 | 296 | 22.83 | 20.67 | 0.47 | KM Plot |
CESC | rs17375328 | chr12:12485292 | T/C | 0 | 298 | 22.88 | 20.63 | 0.47 | KM Plot |
CESC | rs17400968 | chr1:165094293 | T/C | 6.53E-5 | 289 | 22.4 | 21.3 | 9.17 | KM Plot |
CESC | rs17401901 | chr5:96091925 | C/T | 1.36E-5 | 296 | 21.17 | 24.53 | 5.1 | KM Plot |
CESC | rs17481759 | chr5:96114695 | A/G | 1.23E-5 | 298 | 21.33 | 24.08 | 5.1 | KM Plot |
CESC | rs17481856 | chr5:96116808 | G/A | 1.23E-6 | 298 | 21.33 | 24.17 | 6.73 | KM Plot |
CESC | rs17504173 | chr1:112309926 | A/G | 0 | 298 | 21.33 | 20.47 | 4.07 | KM Plot |
CESC | rs17569368 | chr1:112303791 | A/T | 0 | 298 | 21.33 | 20.47 | 4.07 | KM Plot |
CESC | rs1811483 | chr3:161130900 | A/G | 1.79E-5 | 292 | 22.83 | 21.4 | 20.15 | KM Plot |
CESC | rs1829453 | chr17:35809843 | A/G | 4.33E-5 | 291 | 21.4 | 23.78 | 8.45 | KM Plot |
CESC | rs1863820 | chr10:88153925 | T/C | 2.08E-14 | 296 | 3.33 | 24.3 | 21.17 | KM Plot |
CESC | rs1863821 | chr10:88150602 | A/G | 3.12E-14 | 293 | 3.33 | 24.6 | 21.17 | KM Plot |
CESC | rs1891370 | chr10:135073395 | G/A | 3.61E-8 | 292 | 9.03 | 21.97 | 21.4 | KM Plot |
CESC | rs1896512 | chr10:88199157 | G/A | 1.18E-14 | 298 | 3.33 | 24.9 | 21.17 | KM Plot |